-
1
-
-
0027465021
-
Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia
-
Dagogo-Jack SE, Craft S, Cryer PE. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest. 1993;91:819-828.
-
(1993)
J Clin Invest.
, vol.91
, pp. 819-828
-
-
Dagogo-Jack, S.E.1
Craft, S.2
Cryer, P.E.3
-
2
-
-
84880720681
-
Mechanisms of hypoglycemia-associated autonomic failure in diabetes
-
Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med. 2013;369:362-372.
-
(2013)
N Engl J Med.
, vol.369
, pp. 362-372
-
-
Cryer, P.E.1
-
3
-
-
84881505727
-
Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: Results from the T1D Exchange clinic registry
-
Weinstock RS, Xing D, Maahs DM, et al. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. J Clin Endocrinol Metab. 2013;98:3411-3419.
-
(2013)
J Clin Endocrinol Metab.
, vol.98
, pp. 3411-3419
-
-
Weinstock, R.S.1
Xing, D.2
Maahs, D.M.3
-
4
-
-
31844437817
-
Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway
-
Skrivarhaug T, Bangstad HJ, Stene LC, Sandvik L, Hanssen KF, Joner G. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia. 2006;49:298-305.
-
(2006)
Diabetologia
, vol.49
, pp. 298-305
-
-
Skrivarhaug, T.1
Bangstad, H.J.2
Stene, L.C.3
Sandvik, L.4
Hanssen, K.F.5
Joner, G.6
-
5
-
-
34247863937
-
Long-term effect of diabetes and its treatment on cognitive function
-
Diabetes Control and Complications Trial. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med. 2007;356:1842-1852.
-
(2007)
N Engl J Med.
, vol.356
, pp. 1842-1852
-
-
-
6
-
-
35848949770
-
Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989
-
Patterson CC, Dahlquist G, Harjutsalo V, et al. Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989. Diabetologia. 2007;50:2439-2442.
-
(2007)
Diabetologia
, vol.50
, pp. 2439-2442
-
-
Patterson, C.C.1
Dahlquist, G.2
Harjutsalo, V.3
-
7
-
-
84898444019
-
The artificial pancreas: Current status and future prospects in the management of diabetes
-
Peyser T, Dassau E, Breton M, Skyler JS. The artificial pancreas: current status and future prospects in the management of diabetes. Ann N Y Acad Sci. 2014;1311:102-123.
-
(2014)
Ann N Y Acad Sci.
, vol.1311
, pp. 102-123
-
-
Peyser, T.1
Dassau, E.2
Breton, M.3
Skyler, J.S.4
-
8
-
-
77956071742
-
Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes
-
Castle JR, Engle JM, El Youssef J, et al. Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes. Diabetes Care. 2010;33:1282-1287.
-
(2010)
Diabetes Care
, vol.33
, pp. 1282-1287
-
-
Castle, J.R.1
Engle, J.M.2
El Youssef, J.3
-
9
-
-
84926287781
-
Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: An open-label randomised controlled crossover trial
-
Haidar A, Legault L, Messier V, Mitre TM, Leroux C, Rabasa-Lhoret R. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. Lancet Diabetes Endocrinol. 2015;3:17-26.
-
(2015)
Lancet Diabetes Endocrinol.
, vol.3
, pp. 17-26
-
-
Haidar, A.1
Legault, L.2
Messier, V.3
Mitre, T.M.4
Leroux, C.5
Rabasa-Lhoret, R.6
-
10
-
-
84904574791
-
Outpatient glycemic control with a bionic pancreas in type 1 diabetes
-
Russell SJ, El-Khatib FH, Sinha M, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med. 2014;371:313-325.
-
(2014)
N Engl J Med.
, vol.371
, pp. 313-325
-
-
Russell, S.J.1
El-Khatib, F.H.2
Sinha, M.3
-
11
-
-
84878963672
-
Mechanisms of glucagon degradation at alkaline pH
-
Caputo N, Castle JR, Bergstrom CP, et al. Mechanisms of glucagon degradation at alkaline pH. Peptides. 2013;45:40-47.
-
(2013)
Peptides
, vol.45
, pp. 40-47
-
-
Caputo, N.1
Castle, J.R.2
Bergstrom, C.P.3
-
12
-
-
84872075509
-
Effects of excipients on the chemical and physical stability of glucagon during freeze-drying and storage in dried formulations
-
Fang WJ, Qi W, Kinzell J, Prestrelski S, Carpenter JF. Effects of excipients on the chemical and physical stability of glucagon during freeze-drying and storage in dried formulations. Pharm Res. 2012;29:3278-3291.
-
(2012)
Pharm Res.
, vol.29
, pp. 3278-3291
-
-
Fang, W.J.1
Qi, W.2
Kinzell, J.3
Prestrelski, S.4
Carpenter, J.F.5
-
13
-
-
84926347273
-
Development of a highly stable, nonaqueous glucagon formulation for delivery via infusion pump systems
-
Newswanger B, Ammons S, Phadnis N, et al. Development of a highly stable, nonaqueous glucagon formulation for delivery via infusion pump systems. J Diabetes Sci Technol. 2015;9: 24-33.
-
(2015)
J Diabetes Sci Technol.
, vol.9
, pp. 24-33
-
-
Newswanger, B.1
Ammons, S.2
Phadnis, N.3
-
14
-
-
84962109502
-
Nonaqueous, mini-dose glucagon for treatment of mild hypoglycemia in adults with type 1 diabetes: A dose-seeking study
-
Haymond MW, Redondo MJ, McKay S, et al. Nonaqueous, mini-dose glucagon for treatment of mild hypoglycemia in adults with type 1 diabetes: a dose-seeking study. Diabetes Care. 2016;39:465-468.
-
(2016)
Diabetes Care
, vol.39
, pp. 465-468
-
-
Haymond, M.W.1
Redondo, M.J.2
McKay, S.3
-
15
-
-
84873788596
-
Toxicity and primary irritation of some chemical compounds following oral administration and skin application
-
Draize JH, Alvarez E, Whitesell MF. Toxicity and primary irritation of some chemical compounds following oral administration and skin application. Federation Proc. 1946;5:174.
-
(1946)
Federation Proc.
, vol.5
, pp. 174
-
-
Draize, J.H.1
Alvarez, E.2
Whitesell, M.F.3
-
16
-
-
0034820852
-
Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes
-
Haymond MW, Schreiner B. Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes. Diabetes Care. 2001;24:643-645.
-
(2001)
Diabetes Care
, vol.24
, pp. 643-645
-
-
Haymond, M.W.1
Schreiner, B.2
-
17
-
-
84947923764
-
Minimizing morbidity of hypoglycemia in diabetes: A review of mini-dose glucagon
-
Chung ST, Haymond MW. Minimizing morbidity of hypoglycemia in diabetes: a review of mini-dose glucagon. J Diabetes Sci Technol. 2015;9:44-51.
-
(2015)
J Diabetes Sci Technol.
, vol.9
, pp. 44-51
-
-
Chung, S.T.1
Haymond, M.W.2
-
18
-
-
78649882282
-
Insulin-induced hypoglycemia increases hepatic sensitivity to glucagon in dogs
-
Rivera N, Ramnanan CJ, An Z, et al. Insulin-induced hypoglycemia increases hepatic sensitivity to glucagon in dogs. J Clin Invest. 2010;120:4425-4435.
-
(2010)
J Clin Invest.
, vol.120
, pp. 4425-4435
-
-
Rivera, N.1
Ramnanan, C.J.2
An, Z.3
|